Published in Gene Therapy Weekly, January 6th, 2005
According to published research from Wales, "`herpes simplex virus (RSV)-derived vectors have been suggested for potential use in gene therapy for Parkinson disease (PD). HSV naturally infects adult neuronal cells and possesses a large genome for the insertion of transgenes."
"In the present study, we have used two different HSV constructs to deliver glial cell line-derived neurotrophic factor (GDNF) to the striatum, and to assess the neuroprotective effects of the GDNF product in an intrastriatal 6-hydroxydopamine lesion model," C. Monville and colleagues, Cardiff University,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.